GENEART AG has a total of 65 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), United States and Germany. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are SIGMA ALDRICH CO LLC, VECTALYS and CODON DEVICES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 17 | |
#2 | United States | 10 | |
#3 | Germany | 9 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Canada | 5 | |
#6 | China | 5 | |
#7 | Australia | 4 | |
#8 | Brazil | 3 | |
#9 | Hong Kong | 3 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Computer technology | |
#5 | Digital networks | |
#6 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Combinatorial chemistry | |
#4 | Measuring microorganism processes | |
#5 | Therapeutic chemical compounds | |
#6 | Bioinformatics | |
#7 | Medical preparations | |
#8 | Sugars | |
#9 | Digital information transmission | |
#10 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Liss Michael | 30 |
#2 | Wagner Ralf | 25 |
#3 | Graf Marcus | 21 |
#4 | Notka Frank | 17 |
#5 | Raab David | 12 |
#6 | Leikam Doris | 7 |
#7 | Wolf Hans | 4 |
#8 | Poehmerer Thomas | 3 |
#9 | Hammer Diana | 3 |
#10 | Trefzer Axel | 3 |
Publication | Filing date | Title |
---|---|---|
DE102010056289A1 | Process for the preparation of reading frame correct fragment libraries | |
DE102007057802B3 | Steganographic embedding of information in coding genes | |
DE102007052344B3 | Selection of Encoding Nucleic Acid Constructs for the Absence of Frameshift Mutations | |
DE102005037349A1 | Method for the continuous targeted evolution of proteins in vivo | |
DE102005037351B3 | In vitro method for directed evolution of proteins, useful e.g. in pharmaceutical development, uses expression system for performing translation, transcription and reverse transcription | |
EP1776460A2 | Method for modulating gene expression by modifying the cpg content | |
DE102004037652A1 | Method for modulating gene expression by changing the CpG content | |
DE102004037611A1 | Inducible gene expression | |
DE10053781A1 | Nuclear export reporter system |